What is Warticon?
Warticon (podophyllotoxin 0.15% cream) is a prescription topical antimitotic medicine used to treat external genital and perianal warts (condylomata acuminata) caused by the human papillomavirus (HPV). It belongs to the same therapeutic class as Condyline (podophyllotoxin 0.5% solution), differing in its cream formulation and concentration.
Podophyllotoxin, the active ingredient, is a purified plant-derived cytotoxic agent that works by destroying the rapidly dividing cells of HPV-induced warts. Warticon cream is designed for patient self-application as part of a structured treatment cycle.
How does Warticon work?
Podophyllotoxin’s mechanism of action is well characterised as an antimitotic agent:
- Tubulin binding: Podophyllotoxin binds to the protein tubulin, specifically at the colchicine-binding site on the beta-tubulin subunit.
- Microtubule disruption: This binding prevents the polymerisation of tubulin into microtubules, which form the mitotic spindle — the cellular machinery essential for chromosome separation during cell division.
- Mitotic arrest: Without a functional spindle, dividing cells are arrested in the G2/M phase of the cell cycle (just before or during division), unable to complete mitosis.
- Cell necrosis: Cells arrested in mitosis undergo necrosis (death), leading to progressive destruction of the wart tissue over the treatment cycles.
The cream formulation of Warticon differs from the solution (Condyline) in that the vehicle (cream base) allows the active ingredient to remain at the site of application for longer and may penetrate wart tissue in a more controlled manner, potentially reducing the risk of spreading to surrounding healthy skin compared to a liquid solution.
Who is Warticon for?
Warticon cream is suitable for adults with confirmed or clinically assessed external genital and perianal warts who are able to identify the wart tissue clearly and apply the cream accurately.
Particularly appropriate when:
- Warts are located in areas where cream application is easier to control than a liquid solution (e.g., moist perigenital areas)
- The patient finds the cream formulation easier to apply than a solution applicator
- The doctor has assessed that a cream formulation is preferable based on wart characteristics
Warticon is NOT suitable for:
- Pregnant women: Contraindicated due to teratogenic risk
- Internal warts: The cream should not be applied inside the vagina, urethra, or rectum
- Children under 18: Safety not established for this indication
- Large wart areas: More than 4 cm² of total wart surface, or more than 50 separate warts — a doctor should assess suitability
- Immunocompromised patients: May be less effective and can cause more severe local reactions — specialist input is advisable
Posología and Application
Treatment schedule: Apply the cream to each wart twice daily (morning and evening) for 3 consecutive days. Then stop for 4 days. This completes one treatment cycle. Repeat for up to 4 cycles if needed.
| Phase | Days | Action |
|---|---|---|
| Treatment | Days 1, 2, 3 | Apply cream twice daily to warts only |
| Rest | Days 4, 5, 6, 7 | No treatment |
| Repeat | From Day 8 | Up to 3 more cycles |
Instrucciones de aplicación:
- Clean and dry the treatment area before application.
- Apply a small amount of cream precisely to each wart surface using the finger or applicator provided. Avoid healthy surrounding skin.
- Allow the cream to dry and absorb before dressing.
- Wash hands thoroughly after application.
- Avoid sexual intercourse while the cream is on the skin.
- Do not occlude the area with airtight dressings.
Maximum per application: No more than 0.5 mL of cream (approximately a 10 cm² area of wart surface) per session.
Efectos secundarios
Local skin reactions are expected and indicate the medicine is working on wart tissue. Severity depends on the amount applied and individual sensitivity.
Very common side effects
- Burning, stinging, or pain at the treatment site
- Redness (erythema) of wart tissue
- Itching at the application site
- Erosion or superficial ulceration of wart tissue
Efectos secundarios frecuentes
- Inflammation of surrounding skin (if the cream contacts healthy tissue)
- Tenderness or soreness
Efectos secundarios poco frecuentes
- Blistering at or near the treatment site
- Pigmentation changes (may be persistent)
- Drying or scaling of treated area
If severe pain, extensive inflammation, or open sores develop, stop treatment and consult a doctor. Treatment can be restarted when the reaction has subsided.
Systemic effects
Systemic absorption from topical application at recommended doses is minimal. However, if the cream is used on excessively large areas or more frequently than recommended, systemic toxicity (nausea, vomiting, neurological effects) may occur. Adhere strictly to prescribed amounts.
Warticon vs alternative wart treatments
| Treatment | Formulation | Concentration | Mechanism | Treatment Cycle |
|---|---|---|---|---|
| Warticon | Cream | 0.15% podophyllotoxin | Antimitotic | 3 on / 4 off, up to 4 weeks |
| Condyline | Solution | 0.5% podophyllotoxin | Antimitotic | 3 on / 4 off, up to 4 weeks |
| Aldara | Cream | 5% imiquimod | Immune stimulation | 3×/week, up to 16 weeks |
| Cryotherapy | Liquid nitrogen | N/A | Physical destruction | Clinic-based |
Warticon vs Condyline: Both are podophyllotoxin preparations with equivalent efficacy in clinical studies. The cream (Warticon) may be preferred for moist mucosal surfaces and areas where precise application of a solution is difficult, while the solution (Condyline) may be preferred for keratinised skin or drier surfaces.
Warticon vs Aldara: Podophyllotoxin (Warticon) works by direct tissue destruction, while imiquimod (Aldara) stimulates the immune system. Podophyllotoxin is generally faster-acting, while imiquimod may have lower recurrence rates due to its immunostimulatory effect. Clinical selection depends on individual assessment by a doctor.
How to access Warticon online in Europe
Warticon es un medicamento sujeto a prescripción médica en todos los estados miembros de la UE. No puede dispensarse legalmente sin una receta válida de un profesional médico autorizado.
Prescrivia opera como intermediario tecnológico: no prescribimos medicamentos, no empleamos médicos ni vendemos medicamentos. Nuestra plataforma conecta a los pacientes con médicos independientes registrados en la UE que pueden realizar evaluaciones de salud en línea confidenciales.
El proceso:
- Complete una evaluación de salud: Describe the warts — their size, number, location, and duration — along with your sexual health history and any previous wart treatments.
- Revisión médica: Un médico independiente registrado en la UE revisa su evaluación. If Warticon cream is clinically appropriate, they may issue a prescription.
- Dispensación en farmacia: La receta se envía a una farmacia asociada autorizada de la UE para su dispensación y entrega directa.
Importante: Prescrivia no garantiza que se emita una receta. Todas las decisiones de prescripción son tomadas de forma independiente por profesionales médicos cualificados.
Información importante de seguridad
No utilice Warticon si usted:
- Are pregnant or trying to become pregnant
- Are breastfeeding
- Are under 18 years of age
- Are allergic to podophyllotoxin or any ingredient in the cream
- Have open, inflamed, or bleeding skin in the intended treatment area
Informe a su médico si:
- Are immunocompromised (including HIV-positive or on immunosuppressant treatment)
- Have previously used any other wart treatment (including cryotherapy or Aldara)
- Are uncertain whether your lesions are genital warts — other conditions including vulval intraepithelial neoplasia (VIN), molluscum contagiosum, and skin cancers can resemble genital warts and must be excluded
Latex contraception: Podophyllotoxin cream may affect latex condoms and diaphragms. Avoid unprotected sexual contact during treatment.
HPV and recurrence: Treating visible warts removes the physical lesions but does not eliminate the underlying HPV infection. Warts may recur after successful treatment. The virus can be transmitted to sexual partners even when no visible warts are present.
Fuentes
La información médica de esta página se basa en las siguientes fuentes:
- European Medicines Agency (EMA). Podophyllotoxin — Summary of Product Characteristics. Disponible en: ema.europa.eu
- World Health Organization (WHO). Human papillomavirus (HPV) and cervical cancer — Fact sheet. who.int
- Lacey CJ, et al. 2012 European guideline for the management of anogenital warts. Journal of the European Academy of Dermatology and Venereology. 2013;27(3):e28–35.
Este contenido se revisa periódicamente para reflejar las directrices clínicas actualizadas. Se proporciona únicamente con fines informativos y no constituye asesoramiento médico. Consulte siempre a un profesional sanitario cualificado para obtener asesoramiento relevante para sus circunstancias de salud individuales.
Frequently asked questions
- What is Warticon used for?
- Warticon (podophyllotoxin 0.15% cream) is a prescription topical medicine used to treat external genital and perianal warts (condylomata acuminata) caused by the human papillomavirus (HPV) in adults. It destroys wart tissue through an antimitotic mechanism, preventing HPV-infected cells from dividing.
- What is the difference between Warticon and Condyline?
- Both Warticon and Condyline contain podophyllotoxin and follow the same treatment cycle (twice daily for 3 days on, 4 days off). The key differences are: Warticon is a cream formulation at 0.15% concentration, while Condyline is a solution at 0.5% concentration. The cream formulation of Warticon may be easier to apply precisely to warts in moist areas and may cause slightly less local irritation than the solution, though clinical efficacy is comparable.
- How many treatment cycles does Warticon require?
- Warticon is applied for up to four treatment cycles (each cycle: twice daily application for 3 days, followed by 4 days without treatment — one full week per cycle). Many patients see clearance within 2–4 cycles. If warts have not cleared after 4 cycles (4 weeks), a doctor should be consulted to assess alternative or adjunctive treatments.
- Is Warticon safe during pregnancy?
- No. Podophyllotoxin is contraindicated during pregnancy. It can be absorbed through the skin in small amounts and has demonstrated teratogenic (fetus-harming) and embryotoxic effects in animal studies. Women who are pregnant or planning to become pregnant must inform their doctor. Alternative treatments such as cryotherapy may be considered during pregnancy under medical supervision.
- Can I get Warticon online in Europe?
- Warticon es un medicamento sujeto a prescripción médica en todos los estados miembros de la UE. Puede acceder a it through online intermediary platforms that connect you with independent EU-registered doctors for a confidential assessment and, if clinically appropriate, a prescription.
Tratamientos
Prescrivia es únicamente una plataforma intermediaria. No prestamos servicios médicos, no prescribimos tratamientos ni dispensamos medicamentos. Todas las decisiones médicas son tomadas por médicos independientes registrados en la UE. Todos los medicamentos son dispensados por farmacias autorizadas de la UE. Esta plataforma facilita la conexión entre pacientes y profesionales sanitarios.